DIXOMOX-CV ES TAB
MRP: 2,200
Packaging: 10x10
Pack Type: tablet
Composition:
Amoxycillin Trihydrate 600 mg + Clavulanic Acid 42.9 mg
Indication:
Acute exacerbations of chronic diseases, Urinary tract infections, Skin and soft tissue infections, Respiratory tract infections Acute Otitis media, Dental infections
Description:
This formulation combines Amoxycillin Trihydrate 600 mg, a broad-spectrum penicillin antibiotic, with Clavulanic Acid 42.9 mg, a beta-lactamase inhibitor. Together, they offer enhanced efficacy against beta-lactamase-producing bacteria that are resistant to amoxicillin alone.
It is commonly prescribed for:
Upper and lower respiratory tract infections
Otitis media (ear infections)
Sinusitis
Skin and soft tissue infections
Urinary tract infections
This dose is often formulated as a pediatric oral suspension or dispersible tablet, providing convenient and effective treatment for children.
Tags:
- Enhanced action against resistant bacteria
- Broad-spectrum coverage for common pediatric infections
- Beta-lactamase inhibitor reduces treatment failure
- Suitable formulation for children
- Effective and fast-acting
Usage Information
Dosage
Usual Pediatric Dose: As directed by the physician (often based on weight and age) Route: Oral Form: Suspension or dispersible tablet Frequency: Every 12 hours for 5–10 days depending on infection severity Shake well before each use if in suspension form Complete the full course even if symptoms improve early
Side Effects
Common: Diarrhea, nausea, rash, mild abdominal pain Uncommon: Yeast infections (oral thrush), skin itching Serious (rare): Allergic reactions, liver enzyme elevation, severe diarrhea (C. difficile-associated diarrhea)
Contraindications
Hypersensitivity to penicillins or beta-lactams History of cholestatic jaundice or hepatic dysfunction with prior amoxicillin/clavulanate use Should be used with caution in patients with renal impairment Not intended for viral infections